Insurance with coverage for bloodless surgery
Health insurance policies with access to specialized units in Bloodless Medicine and Surgery, committed to their results and their autonomy.
Contact us
Comprehensive care that protects your blood and your decisions,before, during and after surgery.
Bloodless Medicine and Surgery Units (UMCSS) were created with a dual purpose: to improve clinical outcomes by reducing the need for transfusions and, at the same time, to respect the principle of autonomy for patients who, due to ethical, religious, or personal convictions, refuse the use of blood products. To achieve this, they apply a structured care protocol in four phases: a comprehensive case assessment by a multidisciplinary team, preoperative preparation that optimizes hemoglobin levels and iron stores, a procedure using minimally invasive techniques that reduce blood loss, and postoperative follow-up with red blood cell production stimulants to facilitate recovery.
At Grupo Concentra and Gescobert, we have spent over 30 years building a network of medical teams throughout Spain committed to meeting these requirements. We offer health insurance policies that include a bloodless surgery clause, guaranteeing the right to undergo surgery without the use of whole blood or blood products (red blood cells, white blood cells, platelets, or plasma). This coverage includes cardiac, oncological, orthopedic, obstetric, and many other specialties, with specialist locator available 24/7, 365 days a year.
What do we insure?
Preoperative Preparation and Planning
Before the procedure, the medical team performs a thorough patient assessment to optimize hemoglobin levels and iron stores, reducing or eliminating the need for transfusion.
Surgical intervention without blood products
Coverage guarantees access to surgeons specializing in minimally invasive techniques and closed-circuit blood recovery systems, across all specialties.
Post-operative follow-up and recovery
Following surgery, the policy covers the necessary measures to preserve and stimulate the patient's own blood production, including pharmacological treatments and the necessary technical means to facilitate a complete recovery with the highest safety guarantees.
